secwatch.observer — SEC 8-K summary
======================================

Issuer:     Health Catalyst, Inc. (HCAT)
CIK:        0001636422
Form:       8-K
Filed at:   2025-08-07T23:59:59+00:00
Accession:  0001636422-25-000108
Event type: earnings
Sentiment:  neutral
Materiality: 0.70
Item codes: 2.02, 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Health Catalyst Q2 revenue $80.7M (+6% YoY), EBITDA $9.3M beat; CEO to retire June 2026
--------------------------------------------------------------------------------

- Total revenue $80.7M (+6% YoY); Adjusted EBITDA $9.3M; both beat Q2 guidance.
- Net loss widened 203% to $41.0M from $13.5M in prior year.
- CEO Dan Burton to retire effective June 30, 2026; will remain on Board; CEO search initiated.
- Board expanded to 8 directors; Justin Spencer (CFO Eko Health) appointed effective Sep 1, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1636422/000163642225000108/0001636422-25-000108-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1636422/000163642225000108/hcat-20250805.htm
  HTML page:      https://secwatch.observer/filing/0001636422-25-000108

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer